Fosamax Lawsuits: Bellwether Trials Scheduled in Federal, State Fosamax Femur Fracture Litigations, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing plaintiffs in Fosamax lawsuits that allege use of the drug caused patients to sustain painful and debilitating femur fractures

Free Case Review
We continue to hear from women who suffered painful and debilitating femur fractures, allegedly due to long-term use of Fosamax.

Thousands of Fosamax lawsuits ( filed on behalf of women who sustained femur fractures, allegedly due to their use of the medication, continue to move forward in state and federal courts throughout the country, Bernstein Liebhard LLP reports. According to court documents filed in New Jersey’s Atlantic County Superior Court, the proceeding’s first bellwether trial involving femur fracture allegations is expected to get underway in the state’s Fosamax litigation in March. (In re: Fosamax Litigation, No. 282, N.J. Super. Ct) A federal multidistrict litigation established in U.S. District Court, District of New Jersey is expected to proceed with its next trial of a Fosamax femur fracture claim on May 5, 2014. (In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) - MDL No. 224)

“We continue to hear from women who suffered painful and debilitating femur fractures, allegedly due to long-term use of Fosamax. We look forward to the start of these bellwether trials, as they may provide important insight into how juries could rule in similar claims,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing Fosamax lawsuits on behalf of patients who allegedly suffered femur fractures due to their use of this drug.

Fosamax Femur Fracture Allegations
Fosamax is an oral bisphosphonate used to treat a number of bone weakening diseases, including osteoporosis in post-menopausal women. In October 2010, the U.S. Food & Drug Administration (FDA) issued a public health alert regarding an association between use of drugs like Fosamax and atypical femur fractures. Since then, a growing body of research has raised questions about the long-term use of Fosamax, including an FDA-commissioned study published in May 2012 that concluded there was little benefit in taking such drugs for longer than five years due to their association with femur fractures and other side effects.*

Court documents indicate that more than 3,024 Fosamax lawsuits, including many that allege use of the drug caused patients to develop femur fractures, are currently pending in the proceeding underway in Atlantic County Superior Court. The Court concluded its first femur fracture trial last April, with the jury returning a verdict in favor of Merck & Co. (Glynn v. Merck Sharp & Dohme Corp., 3:11- cv-05304)

More than 1,100 Fosamax femur facture lawsuits have been filed in the federal proceeding underway in the District of New Jersey. According to court records, its first bellwether trial actually got underway in March 2013, but was declared a mistrial after the Plaintiff became ill. (Su v. Merck Sharp & Dohme Corp., case number ATL-L-0789-11)

Individuals who developed femur fractures allegedly due to their use of Fosamax may be entitled to compensation for their injury-related damages. To learn more about filing a Fosamax lawsuit, please visit Bernstein Liebhard LLP’s website. Free case reviews may be obtained by calling 800-511-5092.

*, NEJM, May 31, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website